Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend

´ëÇѺñ´¢±â°úÇÐȸÁö 2012³â 53±Ç 10È£ p.686 ~ 690
±èÇü»ó, ÀÌ⿵, Lim Dong-Hun, ±èö¼º, Baik Seung,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇü»ó ( Kim Hyung-Sang ) 
Chosun University School of Medicine Department of Urology

ÀÌ⿵ ( Lee Chang-Yong ) 
Chosun University School of Medicine Department of Urology
 ( Lim Dong-Hun ) 
Chosun University School of Medicine Department of Urology
±èö¼º ( Kim Chul-Sung ) 
Chosun University College of Medicine Department of Urology
 ( Baik Seung ) 
Chosun University College of Medicine Department of Urology

Abstract


Purpose: To identify the prostate cancer detection rate on the patients who had second prostate biopsy out of the patients who were reported negative in their first biopsy.

Materials and Methods: From July 2006 to February 2012, prostate biopsy was performed on 843 patients with over 4 ng/ml and on 618 biopsy negative patients PSA was performed from between 6 months and 9 months after biopsy. On 164 patients, second biopsy was performed, and 42 patients were selected. If there was less than 10% change between PSA before the prostate biopsy and PSA measured during 6 to 9 months after the first biopsy it was considered as no change. If above 10% increase, it was considered increase and if above 10% decrease it was considered as decrease.

Results: The cancer detection rate in PSA increase group was 20%, the detection rate in no change in PSA level but still over the normal range group 8.3%, and that in the PSA decrease group was 0%. When comparing prostate cancer group and non-cancer group, it is more probable to have prostate cancer when they are older, prostate volume is smaller and PSA density is higher.

Conclusions: The second biopsy is strongly recommended when PSA level shows no change or increase, age is older, prostate volume is smaller or PSA density is higher.

Å°¿öµå

Biopsy; Prostate; Prostate-specific antigen; Prostatic neoplasms

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS